Metraipolis › archive › dc_ba2cef4a737b
Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a… — Europe PMC PMID:41159027
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41159027
- DOI
- 10.3389/fimmu.2025.1667733
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T09:04:05.003Z
- SHA-256 of the archived text
d4de977dd2168b5f675cc61d7b164675b9153a1c69cbe3d2579e3ce55848fbe6- Stable URL of this page
https://metraipolis.com/documento/dc_ba2cef4a737b
How to cite
Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a… — Europe PMC PMID:41159027 — Europe PMC (en), https://europepmc.org/article/MED/41159027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ba2cef4a737b (Metraipolis archive dc_ba2cef4a737b, sha256 d4de977dd2168b5f675cc61d7b164675b9153a1c69cbe3d2579e3ce55848fbe6)
BibTeX
@misc{dcba2cef4a737b,
title = {Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a… — Europe PMC PMID:41159027},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41159027},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ba2cef4a737b; sha256 d4de977dd2168b5f675cc61d7b164675b9153a1c69cbe3d2579e3ce55848fbe6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41159027. Agents can read the archived copy with the MCP tool read_document.